AKAN
Akanda Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · GB
$3.35
−8.72%Margins
Gross margin
-71.2%
EBITDA margin
-720.1%
EBIT margin
-877.1%
Net margin
-4537.0%
FCF margin
-1282.6%
460.5%
Return on equity
-801.7%
Return on assets
-278.2%
Return on invested capital
0.18x
Asset turnover
-$10.7M
Cash from operations
$0.93
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025